MK-677 Results
MK-677 results show up as appetite, sleep, fullness, and IGF-1 - but the most important thing to track is the metabolic cost (glucose + insulin), because that is the trade-off that determines whether the results are worth it.
Why measurement beats a before/after photo
MK-677 produces obvious felt effects (hunger, fuller muscles from water, deeper sleep), which makes it feel like it is "working." But the real question is the metabolic cost: it reliably raises fasting glucose and insulin over time. Tracking that trade-off is the difference between a result and a problem.
What to track on MK-677
Confirms the GH-axis response (MK-677 raises IGF-1 reliably).
The key trade-off marker - watch for upward drift, the main downside.
Catches insulin-resistance drift before glucose moves.
90-day glycemic average - the durability check on the metabolic cost.
MK-677 timeline: what tends to shift, when
Appetite + water retention + deeper sleep appear fast. These are the obvious "it works" signals.
IGF-1 reaches its new set point - confirm with a draw.
The metabolic cost builds: fasting glucose and insulin drift upward. This is the window where tracking matters most.
Signal vs placebo: how to tell a real result
The MK-677 felt effects (hunger, fullness, sleep) are real and fast - but they are not the result that matters long-term. The signal to watch is the glucose/insulin trend over months. A 30%+ upward drift in fasting insulin, or glucose creeping out of range, is the signal that the metabolic cost is outrunning the benefit - and you only catch it with quarterly draws against a baseline.
How to actually track MK-677 results
MK-677 is the compound where the metabolic markers are the whole story. Pull fasting glucose, fasting insulin, and HbA1c at baseline, then quarterly while on it, alongside an IGF-1 confirmation at 6 weeks. The IGF-1 and felt effects tell you it is "working"; the glucose/insulin trend tells you whether the result is worth the cost.
Track MK-677 results with MyProtocolStack →